BE905516A - Nouvelle formulation a liberation prolongee. - Google Patents

Nouvelle formulation a liberation prolongee.

Info

Publication number
BE905516A
BE905516A BE1/011554A BE1011554A BE905516A BE 905516 A BE905516 A BE 905516A BE 1/011554 A BE1/011554 A BE 1/011554A BE 1011554 A BE1011554 A BE 1011554A BE 905516 A BE905516 A BE 905516A
Authority
BE
Belgium
Prior art keywords
release formulation
extended release
new extended
pharmaceutically acceptable
substance
Prior art date
Application number
BE1/011554A
Other languages
English (en)
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858524135A external-priority patent/GB8524135D0/en
Priority claimed from GB858524653A external-priority patent/GB8524653D0/en
Priority claimed from GB858531419A external-priority patent/GB8531419D0/en
Priority claimed from GB868603097A external-priority patent/GB8603097D0/en
Priority claimed from GB868605037A external-priority patent/GB8605037D0/en
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE905516A publication Critical patent/BE905516A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BE1/011554A 1985-10-01 1986-09-30 Nouvelle formulation a liberation prolongee. BE905516A (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB858524135A GB8524135D0 (en) 1985-10-01 1985-10-01 Darodipine compositions
GB858524653A GB8524653D0 (en) 1985-10-07 1985-10-07 Pharmaceutical formulations
GB858531419A GB8531419D0 (en) 1985-12-20 1985-12-20 Pindolol compositions
GB868603097A GB8603097D0 (en) 1986-02-07 1986-02-07 Pharmaceutical formulations
GB868605037A GB8605037D0 (en) 1986-02-28 1986-02-28 Oral pharmaceutical compositions

Publications (1)

Publication Number Publication Date
BE905516A true BE905516A (fr) 1987-03-30

Family

ID=27516617

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/011554A BE905516A (fr) 1985-10-01 1986-09-30 Nouvelle formulation a liberation prolongee.

Country Status (20)

Country Link
KR (1) KR920008817B1 (cs)
AT (1) AT402257B (cs)
BE (1) BE905516A (cs)
CA (1) CA1298784C (cs)
CH (1) CH669524A5 (cs)
DE (1) DE3632201C2 (cs)
DK (1) DK170016B1 (cs)
ES (1) ES2002508A6 (cs)
FR (1) FR2589732B1 (cs)
GR (1) GR862457B (cs)
HK (1) HK392A (cs)
HU (1) HU197201B (cs)
IE (1) IE59589B1 (cs)
IL (1) IL80182A (cs)
LU (1) LU86615A1 (cs)
NL (1) NL194822C (cs)
NZ (1) NZ217732A (cs)
PT (1) PT83456B (cs)
SE (1) SE503222C2 (cs)
SG (1) SG103391G (cs)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
WO2003065970A2 (en) * 2001-02-20 2003-08-14 Royal College Of Surgeons Ie Treatment of fibromyalgia and related fatigue syndromes using pindolol
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DD145004A3 (de) * 1978-09-25 1980-11-19 Reinhard Huettenrauch Verfahren zur herstellung fester a zneiformen
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
JPS6056122B2 (ja) * 1980-05-21 1985-12-09 塩野義製薬株式会社 徐放性製剤
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
CA1208558A (en) * 1982-10-07 1986-07-29 Kazuo Kigasawa Soft buccal
GB2154874B (en) * 1984-02-29 1987-11-04 Sandoz Ltd Bromoscriptine compositions
WO1985004100A1 (en) * 1984-03-21 1985-09-26 American Home Products Corporation Sustained release pharmaceutical capsules
JPS6124516A (ja) * 1984-07-12 1986-02-03 Fujisawa Pharmaceut Co Ltd 持続性錠剤

Also Published As

Publication number Publication date
IE862565L (en) 1987-04-01
IE59589B1 (en) 1994-03-09
DK464686A (da) 1987-04-02
HK392A (en) 1992-01-10
PT83456A (en) 1986-10-01
SE503222C2 (sv) 1996-04-22
DE3632201A1 (de) 1987-04-02
NL8602370A (nl) 1987-05-04
LU86615A1 (fr) 1987-04-02
IL80182A0 (en) 1986-12-31
CH669524A5 (cs) 1989-03-31
DE3632201C2 (de) 1997-05-07
HUT44701A (en) 1988-04-28
DK170016B1 (da) 1995-05-01
SE8604112D0 (sv) 1986-09-29
AT402257B (de) 1997-03-25
NL194822B (nl) 2002-12-02
KR920008817B1 (ko) 1992-10-09
HU197201B (en) 1989-03-28
FR2589732B1 (fr) 1989-07-13
DK464686D0 (da) 1986-09-29
GR862457B (en) 1987-01-29
SG103391G (en) 1992-01-17
IL80182A (en) 1991-01-31
CA1298784C (en) 1992-04-14
ES2002508A6 (es) 1988-08-16
KR870003777A (ko) 1987-05-04
FR2589732A1 (fr) 1987-05-15
NZ217732A (en) 1990-07-26
NL194822C (nl) 2003-04-03
PT83456B (pt) 1989-05-12
SE8604112L (sv) 1987-04-02
ATA260486A (de) 1996-08-15

Similar Documents

Publication Publication Date Title
OA09415A (fr) "Composition pharmaceutique pour administration orale à base d'un dérivé d'acide diphosphonique".
ATE41739T1 (de) Feste orale dosierungsformulierungen von kardiovaskularen heilmitteln mit konstanter freisetzungsgeschwindigkeit.
ATA189395A (de) Orale pharmazeutische zubereitung
IT1200178B (it) Formulazioni galeniche a cessione programmata contenenti farmaci ad attivita' antiflogistica
DK0867179T3 (da) Sammensætning af L-DOPA-estere
IL96900A0 (en) Pharmaceutical composition containing naproxen
NO890194L (no) Galenisk middel.
KR900012911A (ko) 흥분성 아미노산 수용기 길항질 화합물
NO883667L (no) Kapsel for farmasoeytisk virksomme innholdsstoffer av en droge.
FR2321892A1 (fr) Preparations pharmaceutiques pour l'administration orale renfermant un ester-17b de nandrolone et nouveaux esters-17b de nandrolone
FR2688405B1 (fr) Procede d'une preparation d'une solution medicinale stable pour voie orale a liberation controlee, a base d'un beta-bloquant, et composition pharmaceutique a base d'un beta-bloquant.
FR2754177B1 (fr) Microspheres pharmaceutiques d'acide valproique pour administration orale
BE905516A (fr) Nouvelle formulation a liberation prolongee.
BE903029A (fr) Nouvelles formes pharmaceutiques administrables par voie nasale.
KR890701087A (ko) 부스피론 및 그의 염의 경구 투여용 제제
BE1002182A5 (fr) Compositions pharmaceutiques.
KR910009257A (ko) 이펜프로딜 및 그의 유도체를 유효성분으로 하는 정신병치료제
GR910100319A (el) Μέ?οδος για την παρασκευή στερεών συν?έσεων περιλαμβανουσών ευαισ?ητοποιημένο εις το φως και δυσκόλως υδατοδιαλυτό ενεργό συστατικό.
BE877703A (fr) Compositions pharmaceutiques a base de trimethoprim et de derives d'acide n-ethyl- -pyridone-3-carboxylique
BE901810A (fr) Compositions de bromocriptine.
FR2598618B1 (fr) Composition pharmaceutique pour ameliorer la constitution des lipides dans le sang
BE880648A (fr) Nouvelles formes galeniques d'administration de medicaments par voie orale, aliberation programmee et leurs procedes de preparation
HK8994A (en) Medicament for treatment of pregnancy-induced hypertension
FR2444462A1 (fr) Compositions pour controler l'hypertension et les troubles intestinaux comprenant un derive de n-aryl n'2-(imidazolidinylidene)-uree
FR2602680B1 (fr) Compositions pharmaceutiques pour l'administration par voie nasale

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *NOVARTIS A.G.

Effective date: 20060930